NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA More...

Array Biopharma (ARRY) Technical (Analysis) Reports Array Biopharma ["Technical Analysis"] Reports -USA Stock Exchange munafasutra.com

Complete & easy to understand technical analysis of Array Biopharma (ARRY)

Technical Analysis Report for USA stock ARRY Array Biopharma. Dated: 16 May 2024 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock ARRY Array Biopharma then click here. or read Experts views on Array Biopharma or Forecast & share price targets of Array Biopharma

Array Biopharma Opened at 12.19 and Closed at: 11.34, which is -7.94% of previous session's close. It moved within a range of 11.16 and 12.35
The session was a Bearish session with an average volume of 9647565, which is 16.68% of previous session's volumes.

• Even though the stock has fallen, but its short term trend is positive and in an uptrend.
• The stock has fallen, and its mid term trend is also negative and in a downtrend.
• The stock has fallen, and its long term trend is also negative and in a downtrend.

A Golden cross was found 9 days back on short term averages

Support for tomorrow is 10.66 and resistance for tomorrow is 11.85
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 10.88, 10.43 resistance for tomorrow's hourly charts is 12.07, 12.81

10 Day SMA for Array Biopharma (ARRY) is 12.72 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Array Biopharma (ARRY) is 12.45 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Array Biopharma (ARRY) is 12.92 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 13.53 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Array Biopharma is 16.57 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Array Biopharma is at 12.45 and 200 DMA is at 16.57, while 50 DMA and 100 DMA are at 12.92 and 13.53 respectively

Array Biopharma (ARRY) moving average of 20 SMA is at 12.45 and 20 EMA is at 12.56

Array Biopharma (ARRY) moving average of 50 SMA is at 12.92 and 50 EMA is at 12.95

Array Biopharma (ARRY) moving average of 100 SMA is at 13.53 and 100 EMA is at 13.86

Array Biopharma (ARRY) moving average of 200 SMA is at 16.57 and 200 EMA is at 15.62

U S has performed better than Array Biopharma in short term. You could have earned much better returns by investing in U S, about 6.61% more returns!

Array Biopharma has performed better than Owens Minor in short term. Holding Array Biopharma could be a better choice for now!

Novartis Ag has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Novartis Ag, about 8.21% more returns!

Davita Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Davita Inc, about 6.16% more returns!

Novocure has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Novocure, about 82.75% more returns!

Mesoblast has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Mesoblast, about 34.12% more returns!

Array Biopharma has performed better than Leap Therapeutics in short term. Holding Array Biopharma could be a better choice for now!

Array Biopharma has performed better than Intra Cellular in short term. Holding Array Biopharma could be a better choice for now!

Iradimed Corporation has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Iradimed Corporation, about 3.4% more returns!

Innoviva Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Innoviva Inc, about 6.27% more returns!

Fibrogen Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Fibrogen Inc, about 7.21% more returns!

Eyenovia Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Eyenovia Inc, about 43.24% more returns!

Array Biopharma has performed better than Citius Pharmaceuticals in short term. Holding Array Biopharma could be a better choice for now!

Array Biopharma has performed better than Co Diagnostics in short term. Holding Array Biopharma could be a better choice for now!

Array Biopharma has performed better than Avadel Pharmaceuticals in short term. Holding Array Biopharma could be a better choice for now!

Array Biopharma has performed better than Aslan Pharmaceuticals in short term. Holding Array Biopharma could be a better choice for now!

Akari Therapeutics has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Akari Therapeutics, about 25.88% more returns!

Array Biopharma Technical analysis of indicators

Price action analysis of Array Biopharma (ARRY) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.

ADX buy sell signal for Array Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Array Biopharma in short term and the sell signal is strong.

Array Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Array Biopharma in short term and SELL signal is strong!

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Array Biopharma is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 12.56 and Array Biopharma ARRY stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Array Biopharma ARRY stock. Volume based technical analysis of Array Biopharma ARRY stock is negative.

Array Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock ARRY Array Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And ARRY Experts View which covers a lot of information including buying and selling signals

ARRY future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Array Biopharma or View Candle Stick Charts here